ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΉ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘
Kern, D., and Lapointe, J. (1980) The catalytic mechanism of glutamyl-tRNA synthetase of Escherichia coli. Evidence for a two-step aminoacylation pathway, and study of the reactivity of the intermediate complex. Eur. j Biochem. 106, 137β150. Solbiati J., Chapman-Smith A., Miller J: L., Miller C.G., and Cronan J.E. (1999) Processing of the N Termini of Nascent Poly peptide Chains Requires… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΉ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘ (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΏΠΈΡΠΎΠΊ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠΉ
- ΠΠΌΠΈΠ½ΠΎΠ°ΡΠΈΠ» ΡΠ ΠΠ ΡΠΈΠ½ΡΠ΅ΡΠ°Π·Ρ
- ΠΠ»ΡΠ±ΠΎΠΌΠΈΡΠΈΠ½
- ΠΠ³ΡΠΎΡΠΈΠ½
- ΠΠΈΠΊΡΠΎΡΠΈΠ½ Π
- ΠΠΈΠΊΡΠΎΡΠΈΠ½ Π‘
- ΠΠΈΠΊΡΠΎΡΠΈΠ½ J
- ΠΠ΅ΠΏΡΠΈΠ΄Π°Π·Ρ.Π. col
- ΠΠΌΠΈΠ½ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·Π° Π
- ΠΠΌΠΈΠ½ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·Π° Π
- ΠΠΌΠΈΠ½ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·Π° N
- ΠΠ΅ΡΠΈΠΎΠ½ΠΈΠ½ΠΎΠ²Π°Ρ Π°ΠΌΠΈΠ½ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·Π°
- ΠΠ»ΠΈΠ³ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·Π° Π
- ΠΠΈΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·Π° D
- ΠΠ΅ΠΏΡΠΈΠ΄Π°Π·Π° Π’
- ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ
- ΠΠ°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΠ΅ ΡΡΠ°ΠΌΠΌΡ
- ΠΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΡΠ΅Π΄Ρ
- ΠΡΠ±ΠΎΡ Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΡ ΠΊΠΎΠ»ΠΎΠ½ΠΈΠΉ ΠΈ ΠΈΡ ΠΏΡΠΎΠ²Π΅ΡΠΊΠ° Π½Π° ΡΡΡΠΎΠΉΡΠΈΠ²ΠΎΡΡΡ ΠΊ Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊΠ°ΠΌ
- ΠΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅Π· Π² Π°Π³Π°ΡΠΎΠ·Π½ΠΎΠΌ Π³Π΅Π»Π΅
- ΠΡΠΎΡΠ΅ΡΡΠΈΠ½Π³ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘
- ΠΠ΅ΡΠΎΠ΄ ΠΠ¦Π
- ΠΠ·Π²Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² ΠΠΠ ΠΈΠ· Π°Π³Π°ΡΠΎΠ·Ρ
- ΠΠΈΠΎΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· Π±Π΅Π»ΠΊΠΎΠ²
- ΠΡΠΈΡΡΠΊΠ° ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘
- ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ S
- ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ S
- ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΏΠ»Π°Π·ΠΌΠΈΠ΄
- ΠΡΠΈΡΡΠΊΠ° ΠΠΠ ΠΎΡ Π±Π΅Π»ΠΊΠΎΠ²ΡΡ ΠΏΡΠΈΠΌΠ΅ΡΠ΅ΠΉ
- Π’ΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΈΡ in vitro
- Π’ΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ E. col
- ΠΠ΅ΡΠ΅ΠΎΡΠ°ΠΆΠ΄Π΅Π½ΠΈΠ΅ ΠΠΠ
- Π Π΅Π°ΠΊΡΠΈΡ Π°ΠΌΠΈΠ½ΠΎΠ°ΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ
- Π’Π₯Π£ ΠΎΡΠ°ΠΆΠ΄Π΅Π½ΠΈΠ΅ Π±Π΅Π»ΠΊΠΎΠ²
- Π‘ΠΈΠ½ΡΠ΅Π· Π»ΡΡΠΈΡΠ΅ΡΠ°Π·Ρ in vitro
- Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅
- ΠΡΠΎΡΠ΅ΡΡΠΈΠ½Π³ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘ Π΄Π΅Π»Π°Π΅Ρ Π΅Π³ΠΎ Π°ΠΊΡΠΈΠ²Π½ΡΠΌ in vitro
- ΠΠ½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½Π°Ρ ΠΌΠΈΡΠ΅Π½Ρ ΠΏΡΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΡΠ‘
- ΠΡΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½ ΠΏΠΎΠ΄Π°Π²Π»ΡΠ΅Ρ ΠΏΠ΅ΡΠ²ΡΡ ΡΡΠ°Π΄ΠΈΡ ΡΠ΅Π°ΠΊΡΠΈΠΈ Π°ΠΌΠΈΠ½ΠΎΠ°ΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ
- Π£ΡΡΠΎΠΉΡΠΈΠ²ΠΎΡΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΊ ΠΡΠ‘ ΠΏΠΎΠ²ΡΡΠ°Π΅ΡΡΡ ΠΏΡΠΈ ΡΡΠΏΠ΅ΡΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠΈ Asp-RS
- Π‘ΡΡΡΠΊΡΡΡΠ° ΠΏΡΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΡΠ‘
- ΠΡΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΠΡΠ‘ ΠΏΠΎΠ΄Π°Π²Π»ΡΠ΅Ρ ΡΠ°Π±ΠΎΡΡ ΡΡΠΊΠ°ΡΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ ΠΠ ΡΠΈΠ½ΡΠ΅ΡΠ°Π·Ρ
- Π‘Π²ΡΠ·ΡΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΡΠ‘ ΠΈ ΠΌΠΈΡΠ΅Π½ΠΈ ΠΎΡΠ΅Π½Ρ ΠΏΡΠΎΡΠ½ΠΎ
- ΠΡΠΎΡΠ΅ΡΡΠΈΠ½Π³ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘ Π² ΡΠΈΡΠΎΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ-ΠΌΠΈΡΠ΅Π½ΠΈ
- ΠΡΠ±Π°Ρ ΠΈΠ· Π°ΠΌΠΈΠ½ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π· Π, Π ΠΈΠ»ΠΈ N ΡΠΏΠΎΡΠΎΠ±Π½Π° ΠΏΡΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°ΡΡ ΠΡΠ‘
- ΠΠ»Π΅ΡΠΊΠΈ, Π»ΠΈΡΡΠ½Π½ΡΠ΅ ΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·, ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡ Π΄Π΅ΡΠΎΡΠΌΠΈΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½
- Π‘ΡΠ°Π΄ΠΈΡ Π΄Π΅ΡΠΎΡΠΌΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Ρ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠ½Π³Π° ΠΈΠ½ΡΠ°ΠΊΡΠ½ΠΎΠ³ΠΎ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π°
- Π€ΠΎΡΠΌΠΈΠ»ΡΠ½Π°Ρ Π³ΡΡΠΏΠΏΠ° ΠΡΠ‘ ΡΡΠ΅Π±ΡΠ΅ΡΡΡ Π΄Π»Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ° Π²Π½ΡΡΡΡ ΠΊΠ»Π΅ΡΠΊΠΈΠΌΠΈΡΠ΅Π½ΠΈ
- Π‘ΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘
- ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠ°Π²Π° Π»ΠΈΠ΄Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΠ΅ΠΏΡΠΈΠ΄Π° ΠΌΠΎΠΆΠ΅Ρ ΠΏΡΠΈΠ²Π΅ΡΡΠΈ ΠΊ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΡΠ‘
- ΠΡΠ²ΠΎΠ΄Ρ
- ΠΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΈ Π°Π²ΡΠΎΡΠ° ΠΏΠΎ ΡΠ΅ΠΌΠ΅ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ
Π²ΡΠ²ΠΎΠ΄Ρ.
1. ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΠΌΠΎΠ΄Π΅Π»ΠΈ «ΡΡΠΎΡΠ½ΡΠΊΠΎΠ³ΠΎ ΠΊΠΎΠ½Ρ» — Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊ Π°ΠΊΡΠΈΠ²Π½ΠΎ ΠΏΠΎΠ³Π»ΠΎΡΠ°Π΅ΡΡΡ ΠΊΠ»Π΅ΡΠΊΠΎΠΉ-ΠΌΠΈΡΠ΅Π½ΡΡ, ΠΏΠΎΡΠ»Π΅ ΡΠ΅Π³ΠΎ ΠΏΡΠ΅ΡΠ΅ΡΠΏΠ΅Π²Π°Π΅Ρ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠ½Π³, ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ΅ΠΌΡΠΉ ΡΠ΅ΡΠΌΠ΅Π½ΡΠ°ΠΌΠΈ ΠΊΠ»Π΅ΡΠΊΠΈ, Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ ΠΏΡΠΈΠΎΠ±ΡΠ΅ΡΠ°Π΅Ρ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠ°.
2. ΠΠ½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΌΠΈΡΠ΅Π½ΡΡ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π‘ ΡΠ²Π»ΡΠ΅ΡΡΡ Π°ΡΠΏΠ°ΡΡΠΈΠ»-ΡΠ ΠΠ-ΡΠΈΠ½ΡΠ΅ΡΠ°Π·Π°, ΠΏΡΠΈΡΡΠΌ Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊ ΡΠΏΠΎΡΠΎΠ±Π΅Π½ in vitro ΠΏΠΎΠ΄Π°Π²Π»ΡΡΡ ΠΊΠ°ΠΊ ΠΏΡΠΎΠΊΠ°ΡΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΉ, ΡΠ°ΠΊ ΠΈ ΡΡΠΊΠ°ΡΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ΅ΡΠΌΠ΅Π½Ρ. ΠΠΊΡΠΈΠ²Π½Π°Ρ ΡΠ°ΡΡΡ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΡΠΎΠ±ΠΎΠΉ Π½Π΅ΡΠ°ΡΡΠ΅ΠΏΠ»ΡΠ΅ΠΌΡΠΉ Π°Π½Π°Π»ΠΎΠ³ ΠΏΡΠΈΡΠΎΠ΄Π½ΠΎΠ³ΠΎ ΡΡΠ±ΡΡΡΠ°ΡΠ° ΡΠ΅Π°ΠΊΡΠΈΠΈ Π°ΠΌΠΈΠ½ΠΎΠ°ΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, Π°ΠΌΠΈΠ½ΠΎΠ°ΡΠΈΠ»Π°Π΄Π΅Π½ΠΈΠ»Π°ΡΠ°.
3. Π‘Π²ΡΠ·ΡΠ²Π°Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΠ°ΡΡΠΈ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° (ΠΏΡΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΡΠ‘) Ρ Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΌΠΈΡΠ΅Π½ΡΡ, ΠΏΠΎ-Π²ΠΈΠ΄ΠΈΠΌΠΎΠΌΡ, Π½Π΅ΠΎΠ±ΡΠ°ΡΠΈΠΌΠΎ.
4. ΠΠ΅ΠΏΡΠΈΠ΄Π½Π°Ρ ΡΠ°ΡΡΡ Π·ΡΠ΅Π»ΠΎΠ³ΠΎ Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊΠ° ΠΈΠ³ΡΠ°Π΅Ρ ΡΠΎΠ»Ρ ΡΠΈΠ³Π½Π°Π»ΡΠ½ΠΎΠΉ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π΄Π»Ρ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ° ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π²Π½ΡΡΡΡ ΠΊΠ»Π΅ΡΠΊΠΈ. N-ΠΊΠΎΠ½ΡΠ΅Π²ΡΠ΅ ΠΈ Π‘-ΠΊΠΎΠ½ΡΠ΅Π²ΡΠ΅ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΠ΅ ΠΎΡΡΠ°ΡΠΊΠΈ ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΠΎΠΉ ΡΠ°ΡΡΠΈ ΠΡΠ‘ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π°ΠΆΠ½Ρ ΠΊΠ°ΠΊ Π΄Π»Ρ ΡΠΎΠ·ΡΠ΅Π²Π°Π½ΠΈΡ Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊΠ° Π² ΠΊΠ»Π΅ΡΠΊΠ΅-ΠΏΡΠΎΠ΄ΡΡΠ΅Π½ΡΠ΅, ΡΠ°ΠΊ ΠΈ Π΄Π»Ρ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ° ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° Π² ΠΊΠ»Π΅ΡΠΊΡ-ΠΌΠΈΡΠ΅Π½Ρ.
5. ΠΡΠΎΡΠ΅ΡΡΠΈΠ½Π³ ΠΈΠ½ΡΠ°ΠΊΡΠ½ΠΎΠ³ΠΎ ΠΌΠΈΠΊΡΠΎΡΠΈΠ½Π° ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ΅Ρ Π»ΡΠ±Π°Ρ ΠΈΠ· Π°ΠΌΠΈΠ½ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π· Π, Π, N ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½Π°Ρ Π΄Π΅ΡΠΎΡΠΌΠΈΠ»Π°Π·Π°. ΠΡΠΎΡΠ΅ΡΡΠΈΠ½Π³ ΠΈΠ΄ΡΡ ΠΎΡ N-ΠΊΠΎΠ½ΡΠ° ΠΊ Π‘-ΠΊΠΎΠ½ΡΡ. ΠΠ»ΡΡΠ΅Π²ΠΎΠΉ ΡΠ΅ΡΠΌΠ΅Π½Ρ Π΄Π΅Π³ΡΠ°Π΄Π°ΡΠΈΠΈ Π±Π΅Π»ΠΊΠΎΠ², MAP, Π½Π΅ ΠΏΡΠΈΠ½ΠΈΠΌΠ°Π΅Ρ ΡΡΠ°ΡΡΠΈΡ Π² ΡΡΠΎΠΌ ΠΏΡΠΎΡΠ΅ΡΡΠ΅, Π²ΠΌΠ΅ΡΡΠΎ Π½Π΅Π³ΠΎ ΠΏΠ΅ΡΠ²ΡΠΉ ΠΌΠ΅ΡΠΈΠΎΠ½ΠΈΠ½ ΠΎΡΡΠ΅ΠΏΠ»ΡΠ΅Ρ Π»ΡΠ±Π°Ρ ΠΈΠ· Π°ΠΌΠΈΠ½ΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π°Π·: Π, Π ΠΈΠ»ΠΈ N. ΠΠ°Π»ΠΈΡΠΈΠ΅ ΡΡΠΆΠ΅Π»ΠΎ ΠΎΡΡΠ΅ΠΏΠ»ΡΠ΅ΠΌΠΎΠ³ΠΎ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΎΡΡΠ°ΡΠΊΠ° Π² ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΠΎΠΉ ΡΠ°ΡΡΠΈ ΠΌΠΎΠΆΠ΅Ρ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Π·Π°ΠΌΠ΅Π΄Π»ΠΈΡΡ ΡΠΊΠΎΡΠΎΡΡΡ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠ½Π³Π°.
ΠΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΈ Π°Π²ΡΠΎΡΠ° ΠΏΠΎ ΡΠ΅ΠΌΠ΅ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ.
Metlitskaya*, A., Kazakov*, Π’., ΠΠΎΡΡΠ΅Π³, A., Pavlova, Π., Praetorius-Ibba, Π., Ibba, Π., Krashenninikov, I., Kolb, V., Khmel', I., and Severinov, K. (2006) Aspartyl-tRNA synthetase is the target of peptidenucleotide antibiotic Microcin C. J. Biol. Chem., 281,18 033−18 042. — Π°Π²ΡΠΎΡΡ Π²Π½Π΅ΡΠ»ΠΈ ΠΎΠ΄ΠΈΠ½Π°ΠΊΠΎΠ²ΡΠΉ Π²ΠΊΠ»Π°Π΄ Π² ΡΠ°Π±ΠΎΡΡ).
Kazakov, Π’., Metlitskaya, A., and Severinov, Π. (2007) Structure-activity analysis of translation inhibitor microcin C. J. Bacteriol., 189,2114−2118.
Severinov, K., Semenova, E., Kazakov, A., Kazakov, Π’., and Gelfand, M. S. (2007) The post-translationally modified microcins. Mol. Microbiol., 65, 1380−1394.
Kazakov, Π’., Vondenhoff, G.H., Datsenko, K.A., Novikova, M., Metlytskaya, A., Wanner, B.L., Severinov, K. (2008) E. coli Peptidases A, B, or N Can Process Translation Inhibitor Microcin C. Bacteriol., 190, 2607−2610.
ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΡΠ°Π±ΠΎΡΡ Π½Π° ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΡΡ .
Molecular Genetics of Bacteria & Phages August 7−12, 2007.
University of Wisconsin-Madison, WI, USA.
Poster presentation," Molecular Mechanism of Action of Microcin Π‘5Π' (Authors: T.S. Kazakov, A.Z. Metlitskaya, K. Severinov).
NIAID Region II Center of Biodefense and Emerging Infectious Disease Research October 7−9,2007.
Northeast Biodefense Center, NY, USA.
Poster presentation, «Molecular Mechanism of Action of Microcin C51» (Authors: T.S. Kazakov, A.Z. Metlitskaya, M. Novikova, K. Datsenko, K. Severinov).
1. Schimmel, Π . (1987) Aminoacyl-tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs. Annu. Rev. Biochem. 56, 125−158.
2. Lapointe, J., and Giege, R. (1991) Transfer RNAs and aminoacyl-tRNA synthetases. Translation in Enkaryotes (Trachsel, H., ed) pp. 35−69, CRC Press Inc., Boca Raton, Florida.
3. Schulman, L. H. (1991) Recognition oftRNAs by aminoacyl-tRNA synthetasesJVog. Nueleic Acid Res. Mol. Biol. 41,23−87.
4. Schimmel, P., and Soil, D. (1979) Aminoacyl-tRNA Synthetases: general features and recognition of transfer RNAs. Annu. Rev. Biochem. 48, 601−648.
5. Hountondji, C., Dessen, P., and Blanquet, S. (1986) Sequence similarities among the family of aminoacyl-tRNA synthetases. Biochimie 68,1071−1078.
6. Mirande, M.' (1991) Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications. Prog. Nucleic Acid Ret. Mol. Biol 40, 95−142.
7. Martinis, S. A., Plateau, P., Cavarelli, J., and Florentz, G. (1999) Aminoacyl-tRNA synthetases: A family of expanding functions, EMBOJ. 18,4591−4596:
8. Ibba, M., and Soil, D. (2000) Aminoacyl-tRNA synthesis, Annu. Rev. Biochem. 69, 617−650.
9. Francklyn, C., Perona, J. J., Puetz, J., and Hou, Y. M. (2002) Aminoacyl-tRNA synthetases: versatile players in the changing theater of translation, RNA 8, 1363−1372'.
10. Arnez, J. G., and Moras, D. (1997) Structural and functional considerations of the aminoacylation reaction, Trends Biochem. Sci. 22, 211−216.
11. Kern, D., and Lapointe, J. (1980) The catalytic mechanism of glutamyl-tRNA synthetase of Escherichia coli. Evidence for a two-step aminoacylation pathway, and study of the reactivity of the intermediate complex. Eur. j Biochem. 106, 137−150.
12. Dibbelt, L., Pachmann, U., and Zachau, H. G. (1980) Serine activation is the rate-limiting step of tRNASer aminoacylation by yeast seryl tRNA synthetase, Nucleic Acids Res. 8, 40 214 039.
13. Dibbelt, L., and Zachau, H. G. (1981) On the rate-limiting step of yeast tRNAPhe aminoacylation, FEBS Lett. 129, 173−176.
14. Eldred, E. W., and Schimmel, P. R. (1972) Investigation of the transfer of amino acid from a transfer ribonucleic acid synthetaseaminoacyl adenylate complex to transfer ribonucleic acid, Biochemistry 11, 17−23.
15. Killmann, II., Braun, M., Herrmann, G., and’Braun, V. (2001) FhuA Barrel-Cork Hybrids Are Active Transporters and Receptors. J. Bacteriol. 183: 3476−3487.
16. System of Streptococcus? pneumoniae R.6. J. Bacteriol- 188,3878−3886:23- Ellis, JI G. & Murphy, P. J. (1981) Mol. Gem Genet. 181- 36−43−24- GelvinS: B. (2000) Ann. Rev. Plant PhysiolPlant Mol. Biol- 51, 223−256.
17. Hayman, G. T. & Farrand, S. K. (1988) J. Bacteriol- 170,1759−1767.
18. Kim, H- & Farrand, S. K. (1997) J. Bacteriol. 179, 7559−7572.27. von Bodman, S. B, HaymanG.T. & FarrandS- K. (1992) i>roc. Natl: AcadSei. USA 89, 643−647.28: P. J. Murphy, M/ E. Tate, fi?. Kerr, Eur. J: Biochem: 115, 539 (1981).
19. EllisJ. G., Kerr, A., Van Montagu, Mi &β’ SchellR (^979)Pf^siolPlantPatholii5,3n319.30: SlotaJ: E. & FarrandS: K.,(1982) Plasmid>&-, 175−186;
20. Reader, J.S., Ordoukhanian, P.T., Kim, J.-G., de Cre’cy-Lagard, V., Ingyu Hwang, I.H., Farrand, S., Schimmel, P. (2005) Major Biocontrol of Plant tumors Targets tRNA Synthetase. Science 309:1533.
21. Baquero F., Bouanchaud D, Martinez-Perez M.C., Fernandez C.(1978) Microcin plasmids: a group of extrachromosomal elements coding forlow-molecular-weight antibiotics in Escherichia coli // J. Bacteriol. V. 135. P. 342−347.
22. Davagnino J., Herrero M., Furlong D., Moreno F., Kolter R. (1986) The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine // Proteins. V. 1. P. 230−238.
23. Connell N., Han Z., Moreno F., Kolter R. (1987) An E. coli promoter induced by the cessation of growth// Mol. Microbiol. V. l.P. 195−201.
24. Genilloud O., Moreno F., Kolter R. (1989) DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17. J. Bacteriol. V. 171. P. 1126−1135.
25. Yorgey P., Davagnino J., Kolter R. (1993) The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase. Mol. Microbiol. V. 9. P." 897−905.
26. Yorgey P., Lee J., Kordel J., Vivas E., Warner P., Jebaratnam D., Kolter R. (1994) Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc. Natl. Acad. Sei. U S A. V. 91. P. 4519−4523.
27. Kelleher N.L., Hendrickson C.L., Walsh C.T. (1999) Posttranslational heterocyclization ofcysteine and serine residues in the antibiotic Microcin B17: distributivity and directionality.
28. Biochemistry. V. 38. P. 15 623−15 630.
29. Gilson L., Mahanty H"K., Kolter R. (1990) Genetic analysis of an MDR-like export system: the secretion of colicin V. EMBO. J. V. 9. P. 3875−3884.
30. Garrido M.C., Herrero M., Kolter R., Moreno F. (1988) The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell // EMBO. J. V. 7. P. 1853−1862.
31. Madison L.L., Vivas E.I., Li Y.M., Walsh C.T., Kolter R. (1997) The leader peptide is essential for the post-translational modification of the DNA-gyrase inhibitor microcin B17. Mol. Microbiol. V. 23. P. 161−168.
32. Breil B.T., Ludden P.W., Triplett E.W. (1993) DNA sequence and mutational analysis of genes involved in the production and resistance of the antibiotic peptide trifolitoxin // J. Bacteriol. V. 175. P. 3693−3702.
33. Liu J. (1994) Microcin B17: posttranslational" modifications and their biological implications. Proc. Natl. Acad. Sei. USA. V. 91. P. 4618−4620.
34. Lavina M., Pugsley A.P., Moreno F. (1986) Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli Kl 2 // J. Gen. Microbiol. V. 132. P. 1685−1693.
35. Khmel' I.A. (1999) Microcins—peptide antibiotics of enterobacteria: genetic control of the synthesis, structure, and mechanism of action // Genetika. V. 35. P. 5−16.
36. Pierrat O.A., and Maxwell A. (2003) The action of the bacterial toxin microcin B17. Insight into the cleavage-religation reaction of DNA gyrase II J. Biol. Chem. V. 278. P. 35 016−35 023.
37. Pierrat O.A., Maxwell A. (2005) Evidence for the role of DNA strand’passage in the mechanism of action of microcin B17 on DNA gyrase // Biochemistry. V. 44. P. 4204−4215.
38. Vizan J.L., Hernandez-Chico C., del C., I, Moreno F. (1991) The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase // EMBO. J. V. 10. P. 467−476.
39. KimiO.K., Ohemeng K., Barrett J.F. (2001) Advances in DNA gyrase inhibitors II Expert. Opin. Investig. Drugs. V. 10. P. 199−212.
40. Metlitskaya, A.Z., Katrukha, G.S., Shashkov, A.S., Zaitsev, D.A., Egorov, Ts.A., and Khmel, I.A. (1995) Structure of microcin C51, a new antibiotic with a broad spectrum of activity. FEBSLett. 357:235−8.
41. Kurepina, N.E., Basyuk, E.I., Metlitskaya, A.Z., Zaitsev, D.A., Khmel, I.A. (1993) Cloning and mapping of the genetic determinants for microcin C51 production and immunity. Mol. Gen. Genet. 241:700−6.
42. Khmel1 I.A., Bondarenko V.M., Manokhina I.M., Basyuk E. L, Metlitskaya A.Z., Lipasova V.A., Romanova Y.M. (1993) Isolation and characterization of Escherichia coli strains producing microcins of B and C types // FEMS. Microbiol. Lett. Ill :269−274.
43. Fomenko, D.E., Metlitskaya, A.Z., Peduzzi, J., Goulard, C., Katrukha, G.S., Gening, L.V., Rebuffat, S., Khmel, I.A. (2003) Microcin C51 plasmid genes: possible source of horizontal gene transfer. Antimicrob. Agents Chemother. 47:2868−74.
44. Novikova, M., A. Metlitskaya, A., K. Datsenko, T. Kazakov, A. Kazakov, B. Wanner, and K. Severinov. (2007) The E. coli Yej ABC transporter is required for the uptake of translation inhibitor microcin C. J. Bacteriol. 189:8361−8365.
45. Guijarro J.T., Gonzalez-PastorJ.E., Baleux F., San Millan J.L., Castilla M.A., Rico M. et al. (1995) Chemical structure and-translation inhibition-studies of the antibiotic microcin, C7 // J. Biol. Chem. V. 270. P. 23 520−23 532.
46. Blond A., Peduzzi J., Goulard C., Chiuchiolo M.J., Barthelemy M., Prigent Y. et al. (1999) The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli // Eur. J. Biochemi V. 259. P.1747−755.
47. Salomon R.A., Farias R.N. (1992) Microcin 25, a novel antimicrobial peptide produced by Escherichia coli II J. Bacteriol V. 174. P. 7428−7435.
48. Wilson K.A., Kalkum M., Ottesen J., Yuzenkova J., Chait B.T., Landick R. et al. (2003) Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail // J. Am. Chem. Soc. V. 125. P: 12 475−12 483.
49. Rosengren K.J., Clark R.J., Daly N.L., Goransson U., Jones A., Craik D.J. (2003) Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone II J. Am. Chem. Soc. V. 125. P. 12 464−12 474.
50. Bayro M.J., Mukhopadhyay J., Swapna G.V., Huang J.Y., Ma L.C., Sineva E. et al. (2003) Structure of antibacterial peptide microcin-J25: a 21-residue lariat protoknot // J. Am. Chem. Soc. V. 125. P. 12 382−12 383.
51. Rosengren K.J., Blond A., Afonso C., Tabet J.C., Rebuffat S., Craik D.J. (2004) Structure of thermolysin cleaved microcin J25: extreme stability of a two-chain antimicrobial peptide devoid of covalent1 links II Biochemistry. V. 43. P. 4696−4702.
52. Solbiati J.O., Ciaccio M., Farias R.N., Salomon R.A. (1996) Genetic analysis of plasmid determinants for microcin J25 production and immunity // J. BacterioI. V. 178. P. 3661−3663.
53. Solbiati J.O., Ciaccio M., Farias R.N., Gonzalez-Pastor J.E., Moreno F., and. Salomon R.A. (1999) Sequence analysis of the four plasmid^ genes required to produce the circular peptide antibiotic microcin J25 II J. Bacteriol. V. 181. P. 2659−2662.
54. Delgado M.A., Vincent P.A., Farias R.N., Salomon R.A. (2005) Yojl of Escherichia coli functions as a microcin J25 efflux pump // J. Bacteriol. V. 187. P. 3465−3470.
55. Salomon R.A., Farias R.N. (1993) The FhuA protein is involved in microcin 25 uptake // J. Bacteriol. V. 175. P. 7741−7742.
56. Braun V., Patzer S.I., Hantke K. (2002) Ton-dependent colicins and microcins: modular design and evolution // Biochimie. V. 84. P. 365−380.
57. Darst S.A. (2004) New inhibitors targeting bacterial RNA polymerase // Trends. Biochem. Sei. V. 29. P. 159−160.
58. Mukhopadhyay J., Sineva E., Knight J., Levy RM., Ebright R: H. (2004) Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel // Mol. Cell V. 14. P. 739−751.
59. Adelman K., Yuzenkova J., La Porta A., Zenkin N., Lee J., Lis J. T., Borukhov S., Wang M. D., Severinov K. (2004) Molecular mechanism of transcription inhibition by peptide antibiotic Microcin J25 //. Mol Cell V. 16. P. 753−762.
60. Vincent P.A., Bellomio A., de Arcuri B.F., Farias R.N., Morero R.D. (2005) MccJ25 C-terminal is involved in RNA-polymerase inhibition but not in respiration inhibition-// Biochem. Biophys. Res. Commun. V. 331. P. 549−551.
61. Rintoul M.R., de Arcuri B.F., Salomon R.A., Farias R.N., Morero R.D. (2001) The antibacterial action of microcin J25: evidence for disruption of cytoplasmic membrane energization in Salmonella newport // FEMS. Microbiol. Lett. V. 204. P. 265−270.
62. Chandu D., Kumar A., and Nandi D. (2003) PepN, the Major Suc-LLVY-AMC-hydrolyzing Enzyme in Escherichia coli, Displays Functional Similarity with Downstream Processing Enzymes in Archaea and Eukarya. J. Biol. Chem. 278: 5548−5556.
63. Gonzales T.&Robert-Baudouy J. (1996) Bacterial aminopeptidases: Properties and functions. FEMS Microbiology Reviews 18: 319−344.
64. Miller C.G., Strauch K.L., Kukral A.M., Miller J.L., Wingfield P.T., Mazzei G.J., Werfen R.C., Graber P., and Mowa N.R. (1987) N-terminal methionine-specific peptidase in Salmonella typhimurium. PNAS 84: 2718−2722.
65. Strater N., Sherratt DJ., and Colloms S.D. (1999) X-ray structure of aminopeptidase A from Escherichia coli and a model for the nucleoprotein complex in Xer site-specific recombination. EMBOJ. 18:4513−4522.
66. Barrett A.J., Rawlings N.D., and. Woessner J.F. (1998) Handbook of proteolytic enzymes. Academic Press, San Diego, Calif.
67. Vogt V.M. (1970) Purification and properties of an aminopeptidase from Escherichia coli. J.Biol.Chem. 245: 4760−4769.
68. Mathew Z., Knox T.M., and Miller C.G. (2000) Salmonella enterica serovar typhimurium peptidase B is a leucyl aminopeptidase with specificity for acidic amino acids. J. Bacterioh 182: 3383−3393.
69. Suzuki H., Kamatani S., and Kumagai H. (2001) Purification^ and Characterization of aminopeptidase B from Escherichia coli K-12. Biosci. Biotechnol. Biochem. 65: 1549−1558.
70. Addlagatta A., Gay L., and Matthews B.W. (2006) Structure of aminopeptidase N from' Escherichia coli suggests a compartmentalized, gated active site. PNAS 103: 13 339−13 344.
71. Chandu D. & Nandi D. (2003) PepN is the major aminopeptidase in Escherichia coli: insights on substrate spl, 149: 3437−3447.
72. Kumar A. & Nandi D. (2007) Characterization and role of peptidase N from Salmonella enterica serovar typhimurium. Biochemical and Biophysical Research Communications 353: 706−712.
73. Gharbi S., Belaich A., Murgier M., and Lazdunski A. (1985) Multiple Controls Exerted on In Vivo Expression of the pepN in Escherichia coli: Studies with’pepN-lacZ Operon and Protein Fusion Strains. J.Bacteriol. 163: 1191−1195.
74. Lowther W.T., Orville A.M., Madden D.T., Lim S., Rich D.H., and Matthews B.W. (1999) Escherichia coli Methionine Aminopeptidases: Implications of Crystallographic Analyses of the.
75. Native, Mutant, and Inhibited Enzymes for the Mechanism of Catalysis. Biochemistry 38: 76 787 688.
76. Ye Q.-Z., Xie S.-X., Ma Z.-Q., Huang M., and Hanzlik R.P. (2006) Structural basis of catalysis by monometalated methionine aminopeptidase. PNAS103: 9470−9475.
77. Solbiati J., Chapman-Smith A., Miller J: L., Miller C.G., and Cronan J.E. (1999) Processing of the N Termini of Nascent Poly peptide Chains Requires Deformilation Prior to Methionine Removal. Communication. J. Mol. Biol. 290: 607−614.f.
78. Frottin F., Martinez A., Peynot P., Mitra S., Holz R.C., Giglione C., and Meinnel T. (2006) The Proteomics ofN-terminal Methionine Cleavage. Mol. CellProteomics 5:2336−49.
79. Chang S.-Y.P., McGary E.C., and Chang S. (1989) Methionine Aminopeptidase Gene of Escherichia coli Is Essential for Cell Growth. J.Bacteriol. 171: 4071−4072.
80. Conlin C.A.&Miller C.G. (2000) opdA, a Salmonella enterica Serovar Typhimurium Gene Encoding a Protease, Is Part of an Operon Regulated by Heat Shock. J.Bacteriol. 182: 518−521.
81. Schroeder U., Henrich., Fink J., and R.Plapp. (1994) Peptidase D of Escherichia coli K-12 a metallopeptidase of low substrate specificity. FEMS Microbiol. Lett. 123: 153−160.1.
82. Kirsh M., Dembinski D.R., Hartman P.E., and Miller C.G. (1978) Salmonella typhimurium' Peptidase Active on Carnosine. J.Bacteriol. 134: 361−374.
83. Hakansson K.& Miller C.G. (2002) Structure of peptidase T from Salmonella typhimurium. Eur.J. Biochem. 269:443−450.
84. Strauch K.L.&Miller C.G. (1983) Isolation and’Characterization Salmonella typhimurium β’ Mutants Lacking a Tripeptidase (Peptidase T). J.Bacteriol. 154: 763−771.
85. Strauch K.L., Carter T.H., and Miller C.G. (1983) Overproduction of Salmonella typhimurium Peptidase T. J.Bacteriol. 156: 743−751.
86. Strauch K.L., Lenk J.B., Gamble B.L., and Miller C.G. (1985) Oxygen Regulation in Salmonella typhimurium. J.Bacteriol. 161: 673−680.
87. Lombardo > M.-J., Lee A.A., Knox T.M., and Miller C.G. (1997) Regulation of the Salmonella typhimurium pepT gene by cyclic AMP receptor protein (CRP) and FNR acting at a hybrid CRP-FNR site. J. Bacteriol. 179: 1909;1917.